lactobacillu
casei
strain
shirota
select
bacteri
carrier
develop
live
mucos
vaccin
coronaviru
kda
fragment
transmiss
gastroenter
coronaviru
tgev
spike
glycoprotein
use
model
coronaviru
antigen
glycoprotein
clone
lactobacillus
coli
shuttl
vector
express
secret
glycoprotein
recombin
lactobacilli
detect
via
immunoblot
oral
immun
balbc
mice
recombin
lc
constitut
express
kda
fragment
glycoprotein
induc
local
mucos
system
immun
respons
tgev
maximum
titer
igg
ngml
serum
iga
ngml
intestin
water
attain
day
post
oral
inturb
induc
antibodi
demonstr
neutral
effect
tgev
infect
although
parenter
vaccin
usual
highli
effect
elicit
protect
immun
respons
respons
obtain
necessarili
one
desir
mani
viral
bacteri
parasit
pathogen
enter
bodi
via
mucos
surfac
effect
protect
mucos
infect
requir
develop
vaccin
abl
induc
protect
local
immun
respons
order
neutral
pathogen
infect
point
achiev
via
oral
vaccin
oral
administr
antigen
might
stimul
natur
rout
infect
effect
method
immun
principl
antibodi
type
involv
mucos
immun
secretori
immunoglobulin
major
releas
gastrointestin
fluid
saliva
tear
urin
secret
besid
conveni
less
expens
mucos
immun
offer
sever
advantag
parenter
administ
vaccin
wherebi
enhanc
vaccin
efficaci
simultan
induc
mucos
system
immun
also
minim
advers
vaccin
effect
avoid
direct
contact
potenti
toxic
vaccin
compon
system
circul
lactobacillu
strain
number
properti
make
attract
candid
deliveri
vehicl
present
mucosa
compound
pharmaceut
interest
particular
vaccin
immunomodul
lactobacilli
use
ferment
preserv
food
decad
consid
gener
regard
safe
gra
microorgan
addit
lactobacilli
abl
surviv
transit
upper
gastrointestin
tract
certain
strain
report
abl
colon
intestin
tract
find
indic
certain
lactobacillu
spp
induc
nonspecif
immunoadjuv
effect
provok
sever
studi
aim
determin
capabl
feasibl
applic
bacteria
safe
oral
vaccin
transmiss
gastroenter
coronaviru
tgev
member
genu
coronaviru
famili
coronavirida
order
nidoviral
enteropathogen
coronaviru
caus
highli
fatal
acut
diarrhea
newborn
pig
estim
cost
us
pig
produc
million
dollar
annual
due
death
poor
growth
infect
pig
viral
genom
consist
singlestrand
positivesens
kb
rna
construct
three
major
structur
protein
phosphoryl
nucleoprotein
n
protein
two
glycoprotein
membran
spike
protein
protein
membraneanchor
domain
highli
glycosyl
also
thought
viral
attach
protein
interact
cell
receptor
porcin
aminopeptidas
n
apn
major
induc
tgevneutr
antibodi
protein
use
mainli
induct
protect
immun
tgev
protect
suckl
piglet
tgev
infect
base
uptak
specif
lactogen
antibodi
mainli
iga
class
milk
tgevimmun
sow
studi
potenti
use
lactobacillu
casei
shirota
lc
express
heterolog
coronavir
protein
act
antigen
carrier
oral
vaccin
analyz
viral
antigen
use
kda
fragment
tgev
glycoprotein
encompass
four
major
antigen
domain
critic
neutral
constitut
lactobacillu
express
system
assembl
plasmid
vector
seri
design
use
studi
immunogen
recombin
lc
analyz
post
intragastr
administr
live
bacteria
mice
knowledg
first
report
clone
express
viral
antigen
lactobacilli
data
also
indic
orogastr
intub
recombin
lc
could
induc
specif
immun
respons
tgev
l
casei
shirota
isol
yakult
cultur
milk
singapor
grown
mr
broth
difco
laboratori
detroit
usa
c
continu
shake
rpm
l
casei
shirota
label
protein
dye
five
carboxyfluorescein
diacet
succinimidyl
ester
cfdase
molecular
probe
usa
mg
nonfluoresc
membran
perm
ester
nonspecif
prokaryot
eukaryot
intracellular
esteras
convert
fluoresc
deriv
turn
coval
link
intracellular
protein
via
probe
succinimidyl
group
logphas
cultur
lc
harvest
wash
twice
steril
phosphatebuff
salin
pb
adjust
concentr
cfu
ml
prior
label
cfdase
c
min
stock
solut
cfdase
prepar
first
dissolv
dimethyl
sulfoxid
l
merck
darmstadt
germani
dilut
ethanol
ml
reagent
grade
solut
filter
steril
acrodisc
filter
gelman
aliquot
store
c
fluoresc
label
termin
pellet
bacteria
wash
twice
pb
remov
excess
cfdase
resuspend
pellet
pb
eightweekold
femal
balbc
mice
obtain
laboratori
anim
centr
nation
univers
singapor
maintain
anim
hold
unit
depart
microbiolog
nation
univers
singapor
free
access
standard
mous
diet
water
group
mice
oral
dose
approxim
cfdaselabel
lactobacilli
orogastr
intub
control
mice
oral
fed
steril
pb
group
three
mice
sacrif
day
dose
co
asphyxi
intestin
extract
mous
cut
longitudin
visibl
residu
food
particl
fecal
materi
first
remov
intestin
examin
presenc
adher
cfdaselabel
lc
perform
ad
l
pb
everi
cm
tissu
dislodg
microb
mucos
surfac
tissu
aid
plunger
syring
ml
terumo
tokyo
japan
cell
extract
fix
formaldehyd
vv
prior
flow
cytometri
analysi
amount
cfdasestain
lc
intestin
cell
extract
enumer
count
refer
glass
bead
includ
sampl
use
epic
elit
flow
sorter
coulter
miami
fl
excit
wavelength
argon
laser
sort
sens
flow
cell
kpa
pressur
upon
excit
nm
flow
cytomet
cfdase
give
maxim
emiss
signal
green
nm
data
record
file
format
use
coulter
epic
elit
version
softwar
analyz
convert
plot
use
winmdi
j
trotter
scripp
research
institut
la
jolla
ca
dna
manipul
perform
accord
standard
procedur
kbp
cdna
fragment
nucleotid
encod
ntermin
glycoprotein
tgev
miller
strain
rtgev
first
synthes
via
revers
transcript
viral
rna
amplifi
polymeras
chain
reaction
subclon
topoxl
vector
invitrogen
california
usa
subsequ
dna
fragment
clone
lactobacillus
coli
shuttl
vector
kind
gift
prof
pouwel
ph
tnonutrit
food
research
institut
netherland
control
constitut
promot
l
lactat
dehydrogenas
lldh
gene
yield
construct
verifi
nucleotid
sequenc
electropor
carri
describ
method
josson
et
al
brief
plasmid
dna
g
ad
l
lc
cfu
ml
suspens
subject
singl
electr
puls
f
vcm
recombin
lc
strain
select
mr
medium
contain
gml
erythromycin
presenc
integr
construct
carri
lc
transform
check
extract
plasmid
dna
follow
restrict
analysi
sequenc
overnight
cultur
recombin
lc
lcsrtgev
lc
contain
empti
vector
wild
type
lc
centrifug
g
min
c
supernat
harvest
supernat
obtain
concentr
time
use
ultrafreecl
pbcc
centrifug
filter
unit
millipor
billerica
usa
twenti
microlit
concentr
supernat
respect
cultur
boil
sampl
load
buffer
mm
tri
sd
glycerol
mm
dtt
l
satur
bromophenol
blue
subject
sdspage
polyacrylamid
gel
protein
transfer
electrophoret
onto
nitrocellulos
membran
immunoblot
develop
use
convalesc
swine
serum
tgev
dilut
convalesc
serum
obtain
pig
inocul
oral
rout
tgev
miller
strain
challeng
intramuscularli
day
postinocul
detect
specif
antibodi
bind
horseradish
peroxidas
hrp
conjug
antiswin
igg
zyme
laboratori
inc
san
francisco
usa
dilut
use
visual
immunolabel
band
carri
use
supersign
west
pico
chemiluminesc
substrat
chemiluminesc
reagent
pierc
biotechnolog
rockford
usa
accordingli
manufactur
instruct
group
three
femal
balbc
mice
immun
oral
either
recombin
lc
constitut
express
rtgev
harbor
plasmid
control
nonexpressor
strain
harbor
steril
phosphat
buffer
salin
pb
freshli
cultur
bacteria
harvest
wash
twice
steril
pb
ph
oral
dose
cell
ml
suspens
administ
three
consecut
day
day
booster
immun
given
day
second
booster
given
day
sera
collect
via
tailbleed
collect
intestin
fluid
perform
describ
previous
brief
four
dose
ml
lavag
solut
mm
nacl
mm
na
mm
kcl
mm
nahco
mm
polyethylen
glycol
averag
mw
given
intragastr
min
interv
mice
given
mg
pilocarpin
alconcouvreur
puur
belgium
intraperiton
min
last
dose
lavag
solut
discharg
intestin
content
occur
regularli
next
min
collect
intestin
discharg
brought
ml
pb
vortex
vigor
centrifug
repetit
g
clarif
intestin
content
polystyren
microtitr
plate
coat
overnight
c
g
purifi
tgev
glycoprotein
coat
antigen
extract
cell
lysat
recombin
e
coli
harbor
express
kbp
amino
termin
fragment
protein
form
gstfusion
protein
tgevsgst
purifi
pass
cell
lysat
glutathion
sepharos
affin
column
amersham
bioscienc
inc
buckinghamshir
england
serum
intestin
lavag
sampl
dilut
twofold
use
primari
antibodi
bound
antibodi
detect
use
horseradish
peroxidas
conjug
goat
antimous
iga
igg
zyme
laboratori
inc
san
francisco
usa
follow
colour
develop
use
ophenylen
diamin
dihydrochlorid
sigma
st
loui
usa
substrat
absorb
measur
nm
intestin
fluid
serum
sampl
mice
fed
rtgev
express
lc
evalu
use
plaqu
reduct
assay
determin
neutral
abil
induc
antibodi
lavag
sera
nonexpressor
strain
pb
fed
mice
taken
control
fifti
microlitr
sampl
twofold
serial
dilut
prepar
microcentrifug
tube
tgev
adjust
pfu
l
viru
diluent
concentr
hank
balanc
salt
solut
bovin
serum
albumin
ph
ad
tube
contain
serial
dilut
serum
intestin
lavag
antibodi
viru
mixtur
mix
puls
centrifug
incub
c
hour
twentyfour
well
plate
confluent
monolay
swine
testicular
st
cell
atcc
usa
use
viru
infect
inocul
antibodyviru
mixtur
cell
monolay
rins
viru
diluent
l
antibodyviru
mixtur
ad
appropri
well
plate
left
c
anoth
hour
rock
min
interv
incub
inoculum
remov
cell
monolay
rins
viru
diluent
overlay
medium
equal
volum
concentr
cell
cultur
medium
carboxylmethylcellulos
solut
ad
well
plate
incub
co
incub
c
day
overlay
medium
discard
well
wash
thrice
steril
pb
ph
stain
crystal
violet
solut
differ
number
plaqu
form
treatment
examin
level
signific
student
ttest
analysi
varianc
abil
lc
adher
colon
intestin
mucos
surfac
determin
oral
feed
cfdase
label
lactobacilli
mice
isol
intestin
extract
mice
variou
day
post
orogastr
intub
flow
cytometr
analysi
cell
extract
tabl
indic
portion
oral
fed
lc
abl
surviv
attach
differ
region
murin
intestin
tract
adhes
promin
ileum
cell
detect
ileum
extract
day
seventh
day
amount
lc
remain
adher
intestin
mucos
first
day
duodenum
jejunum
ileum
colon
respect
kbp
fragment
code
amino
terminu
tgev
protein
amplifi
polymeras
chain
reaction
clone
plasmid
plasmid
endogen
regul
element
lactobacillu
downstream
secret
signal
prt
p
gene
l
casei
secret
express
recombin
plasmid
transform
via
electropor
lc
control
purpos
lc
also
transform
empti
vector
express
rtgev
lc
analyz
immunoblot
assay
use
recombin
lc
harbor
either
empti
vector
wild
type
lc
control
western
blot
analysi
supernat
overnight
cultur
lcsrtgev
reveal
protein
band
kda
correspond
expect
molecular
weight
rtgev
fig
lane
reactiv
kda
band
polyclon
tgevspecif
convalesc
swine
serum
gave
indic
immunogen
express
protein
contrast
signal
detect
cultur
medium
cultur
supernat
control
strain
harbor
wild
type
lc
fig
lane
sampl
purifi
recombin
tgev
protein
tgevsgst
also
includ
posit
control
fig
lane
balbc
mice
receiv
three
dose
lc
express
rtgev
day
prime
secondari
respons
rtgev
follow
booster
oral
administr
day
balbc
mice
chosen
model
util
liu
et
al
evalu
immunogen
tgev
dna
vaccin
immunolog
respons
oral
fed
mice
rtgev
determin
probe
blot
concentr
lcsrtgev
supernat
intestin
lavag
sera
extract
mice
detect
kda
rtgev
band
respect
membran
blot
intestin
lavag
sera
indic
mucos
system
immun
respons
tgev
elicit
fig
local
respons
studi
measur
antirtgev
iga
respons
intestin
lavag
post
intragastr
immun
concentr
mucos
iga
antibodi
rtgev
intestin
lavag
determin
via
elisa
use
purifi
tgevsgst
protein
coat
antigen
result
express
titer
determin
express
test
sampl
standard
curv
gener
serial
dilut
commerci
purchas
iga
zyme
laboratori
inc
san
francisco
usa
known
titer
shown
fig
substanti
differ
mucos
iga
level
experiment
group
control
group
prior
intervent
oral
immun
rtgev
express
strain
elicit
antigenspecif
mucos
iga
respons
antibodi
titer
rtgev
specif
respons
balbc
mice
follow
immun
recombin
lc
detect
rapidli
day
rais
titer
ngml
lavag
ngml
lavag
day
respect
sinc
approxim
volum
ml
intestin
lavag
extract
mous
maximum
amount
iga
entir
intestin
tract
would
ng
estim
previou
studi
deriv
intestin
water
cover
surfac
entir
gastrointestin
tract
mice
add
mg
maximum
titer
iga
induc
oral
administr
recombin
lc
amount
ngml
intestin
water
fig
rtgev
specif
local
iga
respons
murin
intestin
lavag
intragastr
immun
group
three
mice
receiv
three
consecut
dose
lcsrtgev
three
time
interv
control
mice
receiv
cfu
lc
contain
group
receiv
buffer
dose
intestin
lavag
collect
day
first
boost
day
second
boost
analyz
via
elisa
use
tgevsgst
coat
antigen
bar
repres
mean
iga
titer
sem
group
likewis
serum
concentr
rtgev
specif
igg
immun
mice
also
determin
anim
oral
fed
rtgev
express
lc
seroconvert
second
dose
fig
elicit
tgev
specif
serum
igg
found
prompter
stronger
comparison
induct
mucos
iga
intestin
titer
ngml
serum
rtgev
specif
igg
attain
first
boost
continu
increas
level
ngml
second
boost
signific
induct
antirtgev
antibodi
observ
control
group
mice
receiv
pb
lc
harbor
empti
vector
fig
taken
togeth
result
recombin
lc
gener
studi
abl
fig
antirtgev
serum
igg
titer
induc
intragastr
immun
recombin
lc
sera
group
three
mice
immun
oral
lc
tgev
expressor
control
nonexpressor
strain
test
presenc
rtgev
specif
igg
elisa
use
tgevsgst
coat
antigen
neg
control
sera
mice
fed
pb
also
assay
bar
repres
mean
igg
titer
sem
group
elicit
tgev
specif
system
mucos
antibodi
respons
upon
oral
administr
plaqu
reduct
assay
perform
determin
whether
antibodi
respons
specif
tgev
glycoprotein
result
demonstr
presenc
antirtgev
iga
igg
cultur
medium
confer
statist
signific
neutral
effect
p
tgev
infect
fig
near
reduct
number
plaqu
consist
observ
plaqu
reduct
assay
carri
use
twoto
eightfold
dilut
intestin
lavag
sera
lcsrtgev
fed
mice
inhibitori
effect
decreas
gradual
dilut
reach
level
similar
buffer
control
control
nonexpressor
strain
dilut
intestin
lavag
sera
respect
mani
pathogen
initi
infect
occur
mucosa
lung
intestin
therefor
import
develop
vaccin
induc
protect
immun
respons
initi
infect
replic
pathogen
prevent
mucosa
via
mucos
immun
mediat
predominantli
secretori
iga
furthermor
sinc
viral
infect
gain
entranc
mucos
surfac
becom
system
vaccin
also
elicit
specif
immun
system
lymphoid
tissu
widespread
threat
mani
emerg
pathogen
virus
sar
coronaviru
hantan
influenza
virus
human
life
challeng
spawn
develop
safe
antivir
vaccin
prevent
use
great
deal
research
current
focus
develop
adequ
mucos
vaccin
variou
vaccin
deliveri
system
explor
oral
applic
date
system
describ
use
lactobacillu
spp
carrier
express
heterolog
bacteri
antigen
form
present
process
immun
system
mammalian
host
studi
engin
first
time
lactobacillu
spp
express
coronavir
protein
tgev
protein
extern
milieu
kda
band
correspond
expect
size
rtgev
detect
supernat
overnight
recombin
lc
cultur
probe
convalesc
swine
serum
henc
indic
recombin
lc
abl
express
secret
protein
fragment
without
compromis
antigen
properti
iga
predomin
antibodi
mucos
surfac
local
produc
level
exce
immunoglobulin
therefor
like
effect
oral
tgev
vaccin
induc
specif
intestin
iga
respons
recombin
lc
shown
abl
elicit
mucos
system
humor
respons
oral
immun
mice
agreement
studi
conduct
enjuan
cowork
likewis
enjuan
cowork
develop
attenu
strain
salmonella
typhimurium
express
amino
terminu
tgev
protein
howev
protein
fragment
encod
construct
typhimurium
lack
antigen
domain
protein
nevertheless
specif
immun
respons
tgev
induc
recombin
typhimurium
though
protect
effect
elicit
antibodi
assess
comparison
two
deliveri
system
illustr
probiot
effect
harmless
natur
lactobacillu
spp
would
render
appropri
oral
vaccin
carrier
nativ
pathogen
bacteria
oral
immun
regim
use
consist
three
set
three
success
daili
dose
experiment
vaccin
adapt
procedur
challacomb
found
pattern
immun
consist
effect
particul
oral
vaccin
use
immun
mice
three
success
daili
dose
recombin
bacteria
requir
order
ensur
system
antibodi
respons
rtgev
elicit
mice
receiv
recombin
lc
intragastr
order
confirm
efficaci
induc
antibodi
inhibit
viru
test
whether
intestin
lavag
sera
inhibit
infect
st
cell
plaqu
reduct
neutral
assay
serum
intestin
sampl
collect
mice
fed
rtgev
express
lc
demonstr
statist
signific
inhibit
reduct
plaqu
format
plaqu
format
tgev
interestingli
despit
lack
posttransl
modif
prokaryot
express
system
kda
fragment
tgev
protein
express
lc
recogn
convalesc
swine
serum
abl
elicit
signific
immun
protect
albeit
low
level
tgev
studi
conduct
hu
et
al
inocul
anim
recombin
e
coli
express
high
level
glycoprotein
induc
neutral
antibodi
confer
protect
vivo
hand
escribano
cowork
develop
arabidopsi
transgen
plant
express
ntermin
domain
tgev
protein
elicit
neutral
antibodi
use
immun
mice
use
plant
oral
vaccin
deliveri
vehicl
howev
would
result
shortterm
induct
immun
system
express
antigen
henc
requir
consist
frequent
feed
mice
transgen
plant
longterm
effect
desir
contrast
develop
deliveri
system
like
lactobacillu
spp
abl
adher
colon
intestin
tract
permit
continu
express
antigen
intestin
result
extend
protect
vaccin
subject
tgev
infect
shown
studi
oral
fed
lc
abl
adher
intestin
tract
mice
percentag
lc
remain
intestin
tract
initi
attach
day
vari
particular
amount
lc
remain
attach
maintain
fairli
constant
percentag
jejunum
ileum
respect
indic
least
onethird
lc
adher
jejunum
ileum
retain
intestin
tract
week
recombin
lc
gener
studi
also
demonstr
similar
adhes
colon
capabl
nativ
counterpart
result
shown
oral
immun
regim
could
develop
base
adher
abil
vaccin
carrier
case
singl
dose
lactobacilli
vaccin
requir
instead
three
consecut
dose
immun
booster
dose
administ
interv
day
instead
day
would
suffici
consist
express
tgev
spike
protein
intestin
present
studi
lc
demonstr
abl
surviv
transit
upper
gastrointestin
tract
abl
express
secret
heterolog
coronavir
protein
induc
specif
immun
respons
antigen
within
murin
intestin
milieu
oral
administ
mechan
secret
antigen
also
abl
transud
intravascular
compart
induc
system
immun
respons
investig
nevertheless
lc
would
serv
potenti
deliveri
vehicl
oral
vaccin
